QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2014     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L), or their combination (T plus L) in the adjuvant trea 期刊论文 2014, 卷号: 32, 期号: 18 作者:  Piccart-Gebhart, Martine J.;  Holmes, Andrew Peter;  Baselga, Jose;  De Azambuja, Evandro;  Dueck, Amylou C. 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/13 DISEASE-FREE SURVIVAL (DFS) IN THE LAPATINIB ALONE ARM AND EXPANDED RESULTS OF THE PHASE III ALTTO TRIAL (BIG 2-06; NCCTG (ALLIANCE) N063D) IN THE ADJUVANT TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER (EBC) 会议论文 ANNALS OF ONCOLOGY, 2014-09-01 作者:  Perez, E. A.;  Holmes, E.;  De Azambuja, E.;  Dueck, A.;  Baselga, J. 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/13 First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L), or their combination T plus L) in the adjuvant treat 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20 作者:  Piccart-Gebhart, Martine J.;  Holmes, Andrew Peter;  Baselga, Jose;  De Azambuja, Evandro;  Dueck, Amylou C. 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/13 First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T -> L), or their combination T plus L) in the adjuvant treat 期刊论文 2014, 卷号: 32, 期号: 15 作者:  Piccart-Gebhart, Martine J.;  Holmes, Andrew Peter;  Baselga, Jose;  De Azambuja, Evandro;  Dueck, Amylou C. 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/13 Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients 会议论文 Meeting of the European-Hematology-Association, Stockholm, SWEDEN, 2014-06-12 作者:  Geyer, Holly L.;  Scherber, Robyn M.;  Dueck, Amylou C.;  Kiladjian, Jean-Jacques;  Xiao, Zhijian 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 GENDER DIFFERENCES AND MPN SYMPTOM BURDEN: AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP (MPN-QOL ISG) 会议论文 HAEMATOLOGICA, 2014-06-01 作者:  Geyer, H.;  Emanuel, R.;  Dueck, A.;  Kiladjian, J. J.;  Xiao, Z. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients 期刊论文 2014, 卷号: 123, 期号: 24, 页码: 3803-3810 作者:  Geyer, Holly L.;  Scherber, Robyn M.;  Dueck, Amylou C.;  Kiladjian, Jean-Jacques;  Xiao, Zhijian 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 GENDER DIFFERENCES AND MPN SYMPTOM BURDEN: AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP (MPN-QOL ISG) 期刊论文 2014, 卷号: 99, 页码: 396-397 作者:  Geyer, H.;  Emanuel, R.;  Dueck, A.;  Kiladjian, J. J.;  Xiao, Z. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 DISEASE-FREE SURVIVAL (DFS) IN THE LAPATINIB ALONE ARM AND EXPANDED RESULTS OF THE PHASE III ALTTO TRIAL (BIG 2-06; NCCTG (ALLIANCE) N063D) IN THE ADJUVANT TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER (EBC) 期刊论文 2014, 卷号: 25 作者:  Perez, E. A.;  Holmes, E. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13